Joseph Michael Fitzgerald, EVP & Group President, Cardiology at BOSTON SCIENTIFIC CORP (BSX), sold 50,000 shares at $106.97 ($5.3M) on 2025-07-01, disclosed to the SEC on 2025-07-02.
Scheduled sale ($5.3M) by EVP & Group President, Cardiology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BSX | SELL | 2025-09-03 | $10.5M | — | Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-06-04 | $11.6M | — | Filing → |